- Report
- February 2021
- 30 Pages
Global
From €2292EUR$2,600USD£2,013GBP
€2865EUR$3,250USD£2,517GBP
- Report
- February 2024
- 120 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- April 2023
- 115 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- October 2024
- 183 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- July 2024
- 183 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- February 2024
- 172 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- May 2024
- 132 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 139 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 131 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 137 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 138 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 136 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 139 Pages
Global
From €4870EUR$5,524USD£4,278GBP
€5730EUR$6,499USD£5,032GBP
- Report
- May 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,213GBP
- Report
- August 2024
- 215 Pages
Global
From €2204EUR$2,500USD£1,936GBP
- Report
- May 2024
- 169 Pages
Global
From €2204EUR$2,500USD£1,936GBP
- Report
- July 2023
- 121 Pages
Middle East, Africa
From €1322EUR$1,500USD£1,162GBP
- Report
- April 2023
- 231 Pages
Global
From €3174EUR$3,600USD£2,788GBP
- Report
- April 2023
- 94 Pages
North America
From €1322EUR$1,500USD£1,162GBP
- Report
- April 2023
- 104 Pages
Asia Pacific
From €1322EUR$1,500USD£1,162GBP

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more